Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study to Assess Participant Satisfaction After Jawline and Neck Treatment

NCT: NCT07794891 · NOT_YET_RECRUITING

NCT IDNCT07794891
StatusNOT_YET_RECRUITING
Start Date2026-09-04
Completion2027-06
SponsorAbbVie (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this study is to evaluate overall participant satisfaction with the jawline and neck. Participants will receive select Juvéderm products and onabotulinumtoxinA in the jaw area and neck per eligibility criteria. The study will measure changes in psychological function, satisfaction with lower face and jawline and skin appearance. Participants will attend visits during the study at a clinical site. The effects of the treatment will be checked by medical assessments, vital signs, physical examinations, checking for side effects, and completing questionnaires.

Frequently Asked Questions

What is Study to Assess Participant Satisfaction After Jawline and Neck Treatment?

Study to Assess Participant Satisfaction After Jawline and Neck Treatment is a clinical trial registered under NCT07794891. Current status: NOT_YET_RECRUITING.

What is the status of NCT07794891?

The current status of NCT07794891 (Study to Assess Participant Satisfaction After Jawline and Neck Treatment) is: NOT_YET_RECRUITING.

When did Study to Assess Participant Satisfaction After Jawline and Neck Treatment start?

Study to Assess Participant Satisfaction After Jawline and Neck Treatment started on 2026-09-04.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.